Active Ingredient Information

Finax contains the active ingredient Finasteride. Finasteride is a type II 5-alpha reductase inhibitor. It works by reducing the levels of dihydrotestosterone (DHT) in the scalp and serum. This helps to reduce hair loss in men with androgenetic alopecia.

Uses and Indications

Finax is primarily prescribed for the treatment of male pattern hair loss. It may also be used to treat benign prostatic hyperplasia (BPH). It is not indicated for use in women or children. Its efficacy in women and children has not been established, and its use may pose specific risks to these populations.

Mechanism of Action

Finax inhibits the enzyme 5-alpha reductase. This enzyme converts testosterone to dihydrotestosterone (DHT). By inhibiting this enzyme, Finax reduces the levels of DHT. Reduced DHT levels lead to decreased hair follicle miniaturization and enhanced hair growth.

Dosage Instructions

Finax is typically prescribed as a 1 mg tablet taken once daily. It can be taken with or without food. Consistency in administration time is recommended. Swallow the tablet whole, do not crush or chew. Individual dosage adjustments are not usually necessary for most patients.

Missed Dose Protocol

If you miss a dose of Finax, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not take a double dose to make up for a missed one. Maintaining a consistent routine is important for the efficacy of the medication.

Storage Guidelines

Store Finax at room temperature, between 20°C to 25°C (68°F to 77°F). Keep the medication in its original packaging until use. Protect from light and moisture. Ensure it is kept out of reach of children and pets. Discard any expired or unused medication properly.

Pharmacokinetics

Finax is well-absorbed after oral administration. It reaches peak plasma concentration within 1-2 hours. The systemic bioavailability is approximately 80%. Finasteride is metabolized in the liver and excreted via urine and feces. It has a half-life of approximately 5-6 hours in men aged 18-60.

Drug Interactions

Finax can interact with other medications that affect hepatic enzyme activity. Cytochrome P450 3A4 inhibitors may alter finasteride levels. Be cautious when co-administering with other drugs metabolized by this pathway. Monitor for potential adverse reactions or efficacy loss.

Side Effects Overview

Common side effects of Finax include decreased libido, erectile dysfunction, and ejaculation disorders. Less commonly, it may cause allergic reactions such as rash, itching, or swelling. Rarely, it can lead to gynecomastia or testicular pain. If severe side effects occur, consult a healthcare professional.

Patient Monitoring Recommendations

Regular monitoring is advised for long-term users of Finax. Periodic assessment of liver function may be necessary. Patients should report new or worsening symptoms. Regular prostate-specific antigen (PSA) testing may be required for men using Finax for BPH management.

Contraindications Details

Finax is contraindicated in patients with known hypersensitivity to Finasteride. It should not be used by women, particularly during pregnancy or breastfeeding. It is also contraindicated in pediatric patients. Careful assessment is required before initiating treatment in individuals with liver disease.

Clinical Efficacy

Clinical trials have demonstrated significant improvements in hair count and quality in men using Finax for androgenetic alopecia. Efficacy in BPH treatment is reflected by reduced prostate size and improved urinary flow rates. Clinical benefits are usually observed after 3-6 months of consistent use.

Patient Counseling Information

Patients should be counseled on the importance of adherence to the prescribed regimen. Inform them that it may take several months to see visible results. Keep track of any side effects or changes in symptoms. Encourage open communication with healthcare providers.

FDA Approval Status

Finax has received FDA approval for the treatment of androgenetic alopecia in men. The approval also covers its use for benign prostatic hyperplasia. It has undergone rigorous testing for safety and efficacy as per FDA regulations.

Handling and Disposal

Handle Finax tablets with care, especially by women who are or may become pregnant. Avoid crushing or breaking tablets. Dispose of expired or unused medication according to local pharmaceutical disposal guidelines. Do not dispose of it via household waste or wastewater.

Alcohol and Dietary Considerations

There are no specific dietary restrictions while taking Finax. Moderate alcohol consumption does not appear to significantly interact with this medication. However, it is advised to maintain a balanced diet and avoid excessive alcohol use to support overall health.

Packaging Information

Finax is typically available in blister packs or bottles. Each package clearly indicates dosage strength and expiry date. Ensure packaging is intact and not tampered with before use. Keep the original packaging for reference and safe storage.